| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.02. | ZignSec AB: Year-end Report 2023 | 3 | GlobeNewswire (Europe) | With interim report for the period 1 October 2023 to 31 December 2023
Full year 2023 in summaryNet revenue amounted to SEK 84.7 (89.9) million, a decrease of 6% compared with the corresponding period... ► Artikel lesen | |
| 23.02. | FM Mattsson Mora Group AB: Year end report January-December 2023 | 4 | GlobeNewswire (Europe) | October-December 2023Net sales were 449.6 MSEK (459.9), a decrease of 2.2% compared to the equivalent quarter in 2023. Organic growth was -4.4%.EBITA was 23.1 MSEK (46.6), an EBITA margin of 5.1% (10.1).... ► Artikel lesen | |
| 23.02. | Seafire AB: Seafire year-end report 2023: Weak margin, but strong cash flow towards the year-end | 34 | GlobeNewswire (Europe) | Revenue increased by 8% to SEK 227 million (210), while operating profit, adjusted EBITA, amounted to SEK 3 million (9) in Q4. A disappointing end to the year, primarily as a result of negative organic... ► Artikel lesen | |
| 23.02. | Lundin Gold Inc.: Lundin Gold Reports Fourth Quarter and Full Year Results | 5 | GlobeNewswire (Europe) | Production and Cost Performance Meets Upgraded Guidance
VANCOUVER, BC, Feb. 22, 2024 /CNW/ - Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG; OTCQX: LUGDF) ("Lundin Gold" or the "Company") is pleased... ► Artikel lesen | |
| 23.02. | Abliva AB: Abliva AB Year-End Report January - December 2023 | 51 | GlobeNewswire (Europe) | 40 Patients Enrolled in Wave 1 of the FALCON Study | Fast Track Designation for KL1333 | Orphan Drug Designation for NV354 in both US and Europe
2023 SummaryImportant events during 2023KL1333The first... ► Artikel lesen | |
| 23.02. | SynAct Pharma AB: SynAct Pharma today publishes the fourth quarter and annual results of 2023 | 53 | GlobeNewswire (Europe) | "We have excellent opportunities before us, and we remain focused on delivering patient, company and shareholder value," said Torbjørn Bjerke, CEO.
October - December 2023The Group's net sales amounted... ► Artikel lesen | |
| 23.02. | Kancera AB: Interim Report Fourth Quarter 2023, October 1 - December 31 | 134 | GlobeNewswire (Europe) | The period in brief - financial summary for the fourth quarterNet sales amounted to SEK 0 million (SEK 0).R&D expenses amounted to SEK 17,1 million (SEK 11,6 million).Operating income amounted to SEK... ► Artikel lesen | |
| 23.02. | Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer | 171 | Business Wire | PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that its previously announced tender offer (the "Offer") to acquire all of the outstanding shares of RayzeBio... ► Artikel lesen | |
| 23.02. | Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio | 129 | Business Wire | PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Mirati Therapeutics, Inc.® ("Mirati"). With the completion... ► Artikel lesen | |
| 23.02. | Sprott Junior Uranium Miners UCITS ETF: Neuer Themen-ETF von HANetf auf Xetra: Zugang zu kleinen und mittleren Unternehmen aus dem Bereich des Uranbergbaus | 162 | Dow Jones News | Seit Freitag ist der Exchange Traded Fund von HANetf in Kooperation mit Sprott Asset Management auf Xetra und Börse Frankfurt handelbar.
Mit dem Sprott Junior Uranium Miners UCITS ETF bekommen Anleger*innen... ► Artikel lesen | |
| 23.02. | Edoc Acquisition Corp. Announces Postponement of Special Meeting of Stockholders on Proposed Business Combination | 321 | GlobeNewswire (Europe) | Victor, NY, Feb. 23, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (Nasdaq: ADOC) ("EDOC") announced today that it has postponed its extraordinary general meeting of its shareholders (the "Meeting")... ► Artikel lesen | |
| 23.02. | Coherus BioSciences, Inc.: Coherus BioSciences Announces New Employment Inducement Grants | 374 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. ("Coherus" or the "Company", Nasdaq: CHRS), today announced that effective February 20, 2024, the compensation committee... ► Artikel lesen | |
| 23.02. | Adamas One Corp.: Adamas One Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c) | 327 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Adamas One Corp. (Nasdaq: JEWL) ("Adamas One," "Adamas" or the "Company"), The Original Lab-Grown Diamond Company, a high-tech company that leverages... ► Artikel lesen | |
| 23.02. | NeuroOne Medical Technologies Corp: NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 289 | GlobeNewswire (Europe) | EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical... ► Artikel lesen | |
| 23.02. | MoneyHero Limited: MoneyHero Group Appoints Rohith Murthy Chief Executive Officer | 352 | GlobeNewswire (Europe) | SINGAPORE, Feb. 23, 2024 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY) ("MoneyHero" or the "Company"), a market-leading personal finance aggregation and comparison platform in Greater Southeast... ► Artikel lesen | |
| 23.02. | Celularity, Inc.: Celularity Announces 1-for-10 Reverse Stock Split | 357 | GlobeNewswire (Europe) | FLORHAM PARK, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Celularity, Inc. (Nasdaq: CELU; CELUW) ("Celularity"), a biotechnology company developing allogeneic cell therapies and advanced biomaterial products... ► Artikel lesen | |
| 23.02. | Ultragenyx Pharmaceutical Inc.: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 202 | GlobeNewswire (Europe) | NOVATO, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for... ► Artikel lesen | |
| 23.02. | TELA Bio, Inc.: TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 228 | GlobeNewswire (Europe) | MALVERN, Pa., Feb. 23, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction... ► Artikel lesen | |
| 23.02. | Mesa Air Group, Inc.: Mesa Air Group Discloses Notice from Nasdaq | 210 | GlobeNewswire (Europe) | PHOENIX, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) ("Mesa" or the "Company") today announced that it received a notice ("Notice") on February 21, 2024 from the Listing... ► Artikel lesen | |
| 23.02. | Looking Glass Labs Ltd: Looking Glass Labs Welcomes Natasha Ingram as New CEO to Spearhead Innovative Open Metaverse Initiatives | 944 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Looking Glass Labs Ltd. ("LGL" or the "Company") (Cboe Canada: NFTX) (OTC: LGSLF) (FRA: H1N) a leading company in the Open Metaverse... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 4.802 |
| BAYER | 3.693 |
| TUI | 3.503 |
| NEL | 3.313 |
| PLUG POWER | 3.087 |
| GAMESTOP | 3.062 |
| RHEINMETALL | 2.344 |
| AMC ENTERTAINMENT | 2.012 |
| SIEMENS ENERGY | 1.838 |
| MERCEDES-BENZ | 1.611 |
| NVIDIA | 1.578 |
| ALIBABA | 1.567 |
| NOVAVAX | 1.516 |
| NORDEX | 1.460 |
| BYD | 1.322 |
| DEUTSCHE BANK | 1.217 |
| DELIVERY HERO | 1.155 |
| AIXTRON SE | 1.118 |
| VOLKSWAGEN | 1.114 |
| RWE | 1.046 |
| TESLA | 1.028 |
| ALLIANZ | 1.018 |
| PALANTIR TECHNOLOGIES | 990 |
| COMMERZBANK | 985 |
| K+S | 895 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
